CarboHyde is a private preclinical pharmaceutical start-up company specializing in the development of carbohydrate-based APIs. Our team consists of a small group of seasoned scientists with over 50 years of cumulative experience in the field of carbohydrate chemistry, analysis, and pharmaceutical development.
The company’s core focus is neurodegenerative diseases, yet we also have other pre-clinical programs in various unmet medical indications.